Related Experiment Videos
Increased plasma catecholamines in patients with Friedreich's ataxia
Summary
Patients with Friedreich's ataxia exhibit elevated plasma catecholamines, indicating sympathetic nervous system hyperactivity. This sympathetic dysfunction may contribute to cardiac complications in Friedreich's ataxia.
Area of Science:
- Neurology
- Cardiology
- Endocrinology
Background:
- Friedreich's ataxia is a rare inherited neurodegenerative disorder.
- Cardiac involvement, particularly left ventricular hypertrophy, is a common complication.
Purpose of the Study:
- To investigate plasma catecholamine levels in patients with Friedreich's ataxia.
- To explore the relationship between sympathetic nervous system activity and cardiac abnormalities in this population.
Main Methods:
- Measured free and conjugated plasma catecholamines (norepinephrine and epinephrine) in 23 Friedreich's ataxia patients and controls.
- Assessed neuromotor impairment and left ventricular hypertrophy (wall thickness > 12 mm).
Main Results:
- Patients with Friedreich's ataxia showed significantly higher mean plasma norepinephrine and epinephrine levels compared to controls.
- 65% of patients had elevated free and/or conjugated catecholamines.
- Increased catecholamines correlated with severe neuromotor impairment and were present in most patients with left ventricular hypertrophy.
Conclusions:
- Friedreich's ataxia is associated with sympathetic nervous system hyperactivity.
- Elevated norepinephrine may trigger myocardial hypertrophy, suggesting potential for early pharmacological intervention to prevent or manage cardiomyopathy.